Literature DB >> 25979467

Gender determines cortisol and alpha-amylase responses to acute physical and psychosocial stress in patients with borderline personality disorder.

Ayako Inoue1, Harumi Oshita2, Yoshihiro Maruyama1, Yoshihiro Tanaka1, Yoshinobu Ishitobi1, Aimi Kawano1, Rie Ikeda1, Tomoko Ando1, Saeko Aizawa1, Koji Masuda1, Haruka Higuma1, Masayuki Kanehisa1, Taiga Ninomiya1, Jotaro Akiyoshi3.   

Abstract

Borderline personality disorder (BPD) is characterized by affective instability, unstable relationships, and identity disturbance. We measured salivary alpha-amylase (sAA) and salivary cortisol levels in all participants during exposure to the Trier Social Stress Test (TSST) and an electric stimulation stress. Seventy-two BPD patients were compared with 377 age- and gender- matched controls. The State and Trait versions of the Spielberger Anxiety Inventory test (STAI-S and STAI-T, respectively), the Profile of Mood State (POMS) tests, and the Beck Depression Inventory (BDI), the Depression and Anxiety Cognition Scale (DACS) were administered to participants before electrical stimulation. Following TSST exposure, salivary cortisol levels significantly decreased in female patients and significantly increased in male patients compared with controls. POMS tension-anxiety, depression-dejection, anger-hostility, fatigue, and confusion scores were significantly increased in BPD patients compared with controls. In contrast, vigor scores were significantly decreased in BPD patients relative to controls. Furthermore, STAI-T and STAI-S anxiety scores and BDI scores were significantly increased in BPD patient compared with controls. DACS scores were significantly increased in BPD patient compared with controls. Different stressors (e.g., psychological or physical) induced different responses in the HPA and SAM systems in female or male BPD patients.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Adrenocorticotropic hormone (ACTH); Alpha-amylase; Borderline personality disorder; Catecholamine; Cortisol; Stress

Mesh:

Substances:

Year:  2015        PMID: 25979467     DOI: 10.1016/j.psychres.2015.04.008

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  6 in total

1.  Dating violence victimization and borderline personality pathology: Temporal associations from late adolescence to early adulthood.

Authors:  Salome Vanwoerden; Jacob Leavitt; Matthew W Gallagher; Jeff R Temple; Carla Sharp
Journal:  Personal Disord       Date:  2019-03

2.  The relationship between personality and the response to acute psychological stress.

Authors:  Yuanyuan Xin; Jianhui Wu; Zhuxi Yao; Qing Guan; André Aleman; Yuejia Luo
Journal:  Sci Rep       Date:  2017-12-04       Impact factor: 4.379

3.  Borderline personality disorder, trauma, and the hypothalamus-pituitary-adrenal axis.

Authors:  Natalie Thomas; Caroline Gurvich; Jayashri Kulkarni
Journal:  Neuropsychiatr Dis Treat       Date:  2019-09-09       Impact factor: 2.570

4.  Targeting the Endocannabinoid System in Borderline Personality Disorder: Corticolimbic and Hypothalamic Perspectives.

Authors:  Sari G Ferber; Reut Hazani; Gal Shoval; Aron Weller
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

5.  Reduced glucocorticoid receptor expression in blood mononuclear cells of patients with borderline personality disorder.

Authors:  José Manuel López-Villatoro; Karina S MacDowell; Marina Diaz-Marsá; Alejandro De La Torre-Luque; Clara Prittwitz; Alejandra Galvez-Merlin; Juan C Leza; Jose L Carrasco
Journal:  Front Psychiatry       Date:  2022-08-02       Impact factor: 5.435

6.  Sex determines cortisol and alpha-amylase responses to acute physical and psychosocial stress in patients with avoidant personality disorder.

Authors:  Yoshihiro Tanaka; Yoshinobu Ishitobi; Ayako Inoue; Harumi Oshita; Kana Okamoto; Chiwa Kawashima; Mari Nakanishi; Saeko Aizawa; Koji Masuda; Yoshihiro Maruyama; Haruka Higuma; Masayuki Kanehisa; Taiga Ninomiya; Jotaro Akiyoshi
Journal:  Brain Behav       Date:  2016-06-14       Impact factor: 2.708

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.